Status:
COMPLETED
Lipid Metabolic Status in Thyroid Carcinoma
Lead Sponsor:
Prof. Dr. I. Chiricuta Institute of Oncology
Collaborating Sponsors:
Iuliu Hatieganu University of Medicine and Pharmacy
Conditions:
Thyroid Carcinoma
Dyslipidemias
Eligibility:
All Genders
18-80 years
Brief Summary
The continuous increase of the incidence of the thyroid cancer in the last years has taken this neoplasia among the first 4 frequent cancers in the cancer registry of the Institute of Oncology "Prof.I...
Detailed Description
Although considered a rare type of cancer with an incidence under 6 cases for 100 000 persons, the thyroid carcinoma is the most frequent endocrine tumor. The incidence of this malignant disease has e...
Eligibility Criteria
Inclusion
- thyroid carcinoma radically treated (surgery, radioiodine, thyroid hormone suppression )
Exclusion
- other causes of high CRP (infection, inflammation)
Key Trial Info
Start Date :
February 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT01487057
Start Date
February 1 2011
End Date
May 1 2012
Last Update
December 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Oncology "Prof.dr.I.Chiricuta"
Cluj-Napoca, Cluj, Romania, 400015